Pharmacological decrease of liver stiffness is pressure-related and predicts long-term clinical outcome

Liver stiffness (LS) as measured by transient elastography is increasingly used to noninvasively assess liver fibrosis. However, LS is efficiently modulated by confounders like arterial and portal pressure (PP). We here study the effect of acute hemodynamic changes on LS (measured by µFibroscan) in...

Full description

Saved in:
Bibliographic Details
Main Authors: Piecha, Felix (Author) , Poth, Tanja (Author) , Seitz, Helmut K. (Author) , Mueller, Sebastian (Author)
Format: Article (Journal)
Language:English
Published: 18 September 2018
In: American journal of physiology. Gastrointestinal and liver physiology
Year: 2018, Volume: 315, Issue: 4, Pages: G484-G494
ISSN:1522-1547
DOI:10.1152/ajpgi.00392.2017
Online Access:Verlag, lizenzpflichtig, Volltext: https://doi.org/10.1152/ajpgi.00392.2017
Verlag, lizenzpflichtig, Volltext: https://journals.physiology.org/doi/full/10.1152/ajpgi.00392.2017
Get full text
Author Notes:Felix Piecha, Mattias Mandorfer, Teresa Peccerella, Ann-Kathrin Ozga, Tanja Poth, Anna Vonbank, Helmut Karl Seitz, Vanessa Rausch, Thomas Reiberger, and Sebastian Mueller
Description
Summary:Liver stiffness (LS) as measured by transient elastography is increasingly used to noninvasively assess liver fibrosis. However, LS is efficiently modulated by confounders like arterial and portal pressure (PP). We here study the effect of acute hemodynamic changes on LS (measured by µFibroscan) in a rodent model of cirrhosis in response to pharmacological modulation of PP by losartan, nitric oxide donors, and propranolol.
Item Description:Gesehen am 21.04.2020
Physical Description:Online Resource
ISSN:1522-1547
DOI:10.1152/ajpgi.00392.2017